-
21
Tousled-like kinase loss confers PARP inhibitor resistance in BRCA1-mutated cancers by impeding non-homologous end joining repair
Published 2025-01-01Subjects: Get full text
Article -
22
-
23
-
24
-
25
Eradication of Krebs-2 primary ascites via a single-injection regimen of cyclophosphamide and double-stranded DNA
Published 2016-12-01Subjects: Get full text
Article -
26
PARP inhibitor‐based treatment in metastatic, castration‐resistant prostate cancer (mCRPC): A systematic review and meta‐analysis
Published 2025-01-01Subjects: Get full text
Article